The injection of radioactive colloids into rheumatoid joints has proved to be a significant advance in the treatment of this disease. After the use of 198Au (Ansell, Crook, Mallard, and Bywaters, 1963) , yttrium 90 (90Y) is now widely accepted as the most satisfactory agent. The advantages ofthis therapy and the most satisfactory technique have been fully reviewed (Gumpel, 1974) . Complications do occur but are uncommon. In a series of 1240 injections, Menkes, Aignan, Galmiche, and Le Go (1972) reported a 4 % incidence of adverse reactions, which included fever and malaise, skin rashes, and needletrack burns. The possibility that neoplastic change might occur has yet to be evaluated in long-term follow-up studies.
Not previously reported has been the complication of acute joint rupture following 90Y injection. We report two such cases which have occurred after 90Y administration in our unit. A 61-year-old woman with seropositive erosive RA for 3 years was admitted for 90Y injection to her left knee after successful treatment of her right knee 3 months previously. The knee was inflamed with soft tissue swelling and a large effusion, but without evidence of a popliteal cyst. A routine injection was performed and the patient discharged 6 days afterwards.
Method
The patient was admitted 63 days after treatment with signs of an acute joint rupture with little evidence of active synovitis or a popliteal cyst. The fluid aspirated was sterile and contained numerous polymorphs. An arthrogram confirmed the diagnosis.
Discussion
Acute joint rupture of the knee in rheumatoid arthritis is a well-recognized complication (Dixon and Grant, 1964) . This is recognized as occurring in early involvement of the joint and is due to a combination of a rise in intra-articular pressure and a weakness in capsular resistance (Jayson, Swannell, Kirk, and Dixon, 1969) . Although not previously reported, we have seen two cases in which acute joint rupture occurred in association with 90Y injection. In both cases there was a significant delay between the injection and the joint rupture which makes it unlikely to be due to direct puncture of the joint or to an acute inflammatory response to the injection. In addition, neither case showed clinical evidence of local sepsis or acute inflammation.
As 90Y, with a half-life of 2-7 days, was particularly chosen because of its slow clearance rate from joints with a mean retention of 91 % at 5 days (Ramsey, 1973) , it is possible that the presence of a radioactive substance sets up a chronic inflammatory response Acute kneejoint rupture after yttrium 90 injection 63 leading to rupture. Alternatively localized capsule necrosis secondary to radiation may occur with eventual rupture.
It is possible, therefore, thaL in these two cases joint rupture was directly associated with the intraarticular injection of radioactive material.
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